These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38153842)

  • 1. Virus-Inspired Glucose and Polydopamine (GPDA)-Coating as an Effective Strategy for the Construction of Brain Delivery Platforms.
    Duan Q; Liu R; Luo JQ; Zhang JY; Zhou Y; Zhao J; Du JZ
    Nano Lett; 2024 Jan; 24(1):402-410. PubMed ID: 38153842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
    Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
    Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
    Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
    Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole.
    Zhang SS; Asghar S; Ye JX; Lin L; Ping QN; Chen ZP; Shao F; Xiao YY
    Nanoscale; 2020 Dec; 12(46):23709-23720. PubMed ID: 33231242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
    Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
    Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles.
    Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X
    Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability.
    Rabanel JM; Piec PA; Landri S; Patten SA; Ramassamy C
    J Control Release; 2020 Dec; 328():679-695. PubMed ID: 32979453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
    Wünsch A; Mulac D; Langer K
    Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lecithin coating as universal stabilization and functionalization strategy for nanosized drug carriers to overcome the blood-brain barrier.
    Wünsch A; Mulac D; Langer K
    Int J Pharm; 2021 Jan; 593():120146. PubMed ID: 33279714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polydopamine surface-modified hyperbranched polymeric nanoparticles for synergistic chemo/photothermal therapy of oral cancer.
    Yin X; Li Z; Zhang Y; Zeng X; Wang Q; Liang Z
    Front Bioeng Biotechnol; 2023; 11():1174014. PubMed ID: 37214280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier.
    Zhang J; Yang T; Huang W; Yu Y; Sun T
    Curr Med Chem; 2022; 29(39):6063-6083. PubMed ID: 35638273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier.
    Zha S; Liu H; Li H; Li H; Wong KL; All AH
    ACS Nano; 2024 Jan; 18(3):1820-1845. PubMed ID: 38193927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
    Ju X; Miao T; Chen H; Ni J; Han L
    Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy.
    Li Y; Hong W; Zhang H; Zhang TT; Chen Z; Yuan S; Peng P; Xiao M; Xu L
    J Control Release; 2020 Jan; 317():232-245. PubMed ID: 31783048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.